Risperidone for attention-deficit hyperactivity disorder in people with intellectual disabilities, Alex Thomson, Stefanos Maltezos, Elena Paliokosta and Kiriakos Xenitidis. DOI: 10.1002/14651858.CD007011.pub2
Complete the form below and we will send an e-mail message containing a link to the selected mrwArticle on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.